ImThera to begin U.S. testing of sleep apnea device

ImThera Medical says the FDA approved an investigational device exemption for a clinical study of its Aura6000 system for obstructive sleep apnea.

ImThera Medical said the FDA approved its investigational device exemption application to initiate a clinical study for its Aura6000 System for obstructive sleep apnea.

Food & Drug Administration (FDA), ImThera Medical Inc.

News Well, Investigational Device Exemption (IDE), Sleep Monitoring/Sleep Apnea

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1BcfpSW